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Received 16 July 2018; revised 23 July 2018; accepted 23 July 2018Our understanding of the multiple systems and their inter-
actions that contribute to musculoskeletal pain has evolved
considerably in recent years. There is a considerable interest
in the role of the immune system in both acute and persistent
musculoskeletal pain states [1,2]. Systemically elevated levels
of proinflammatory cytokines and chemokines have been
revealed in people with musculoskeletal pain. This low-grade
inflammation has been demonstrated in various musculoskele-
tal conditions, such as low back pain [1], neck pain [2], and
radicular pain [3]. In addition, levels of inflammatory bio-
markers are associated with pain severity in people with neck
and shoulder pain [4] and low back pain [1]. Moreover, an ini-
tial study suggests that inflammatory responses in the acute
phase of low back pain may also be related to recovery [5].
In people with and without musculoskeletal pain, levels
of inflammatory biomarkers are influenced by multiple fac-
tors, such as demographic variables (eg, age and gender),
lifestyle factors (eg, physical activity, saturated fat intake,
and sleep quality), psychological factors (eg, depression
and catastrophizing), and various diseases (eg, cardiovascu-
lar and osteoarthritis) [6−8]. These factors can increase
systemic cytokine concentrations via their direct or indirect
action on immune cells and the subsequent release of
inflammatory cytokines and chemokines [7]. Therefore,drug status: Not applicable.
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018 Elsevier Inc. All rights reserved.adjustment for potential confounders is essential to deter-
mine the level of association between low-grade systemic
inflammation, musculoskeletal pain, and recovery.
The importance of adjusting for confounders when mea-
suring systemic cytokine levels is illustrated in a study in
people with multisite persistent pain [6]. In an unadjusted
analysis, systemic levels of CRP, IL-6, and TNF-a (all
proinflammatory biomarkers) were significantly higher in
people with persistent multisite pain. However, after cor-
recting for sociodemographic variables, TNF-a levels were
no longer significantly higher. Subsequently, after correct-
ing for lifestyle, disease, anxiety, and depression, CRP and
IL-6 were no longer significantly associated with pain. Sim-
ilarly, in a study of people with persistent low back pain,
IL-6 levels were no longer significantly associated with
affective pain after correction for sleep quality [1]. These
studies demonstrate that the association between inflamma-
tory biomarkers and the presence of musculoskeletal pain is
potentially confounded by sociodemographic variables,
lifestyle and disease, and anxiety and depression.
Levels of inflammatory biomarkers likely arise from a
complex interplay among the central nervous system,
immune system, endocrine system, psychological factors,
sociodemographic factors, lifestyle, and behavior. In most
studies, it will not be feasible to correct for all possible con-
founders or to add all effect modifiers in the association
model when assessing the relationship between inflamma-
tory biomarkers and musculoskeletal pain or patient recov-
ery. However, we must remain vigilant when assessing and
interpreting associations between systemic cytokine con-
centrations with persistent musculoskeletal pain and recov-
ery. Unfortunately, researchers rarely control for these
I.J. Lutke Schipholt et al. / The Spine Journal 18 (2018) 2162−2163 2163confounding factors in the analyses, or only control for a
small subset of confounders. This may result in incorrect or
overly optimistic conclusions. To address the common
issue of insufficient power to include all potential con-
founding variables, we propose to create a core set of con-
founders that researchers need to correct for in future
multiple regression analyses. This set of confounders can
also be used when deriving a model to predict musculoskel-
etal pain or recovery that includes inflammatory biomarkers
as possible predictor variables. Further insight in the inter-
play between pain, low-grade inflammation, and confound-
ers will result in a better understanding of pain mechanisms
and potential treatment options for people with or at risk of
developing persistent musculoskeletal pain.References
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